IVERIC bio, Inc. Common Stock
ISEE
ISEE was delisted on the 10th of July, 2023.
182 hedge funds and large institutions have $1.71B invested in IVERIC bio, Inc. Common Stock in 2016 Q2 according to their latest regulatory filings, with 45 funds opening new positions, 74 increasing their positions, 39 reducing their positions, and 23 closing their positions.
96% more first-time investments, than exits
New positions opened: 45 | Existing positions closed: 23
90% more repeat investments, than reductions
Existing positions increased: 74 | Existing positions reduced: 39
26% more capital invested
Capital invested by funds: $1.36B → $1.71B (+$353M)
25% more funds holding in top 10
Funds holding in top 10: 4 → 5 (+1)
12% more funds holding
Funds holding: 162 → 182 (+20)
14% less call options, than puts
Call options by funds: $14.2M | Put options by funds: $16.5M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fiera Capital (Canada)
Montreal,
Quebec, Canada
|
+$36.9M |
| 2 |
Millennium Management
New York
|
+$27.7M |
| 3 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
+$21.1M |
| 4 |
TBC
Three Bays Capital
Boston,
Massachusetts
|
+$17.4M |
| 5 |
SIG
Senator Investment Group
New York
|
+$17.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
-$64.6M |
| 2 |
Morgan Stanley
New York
|
-$33.7M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$17.5M |
| 4 |
Renaissance Technologies
New York
|
-$15.3M |
| 5 |
State Street
Boston,
Massachusetts
|
-$10.8M |
ISEE Hedge Fund Activity: Q2 2016 in Review
182 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in IVERIC bio, Inc. Common Stock (ISEE) for Q2 2016, worth a combined $1.71B — up 26% from $1.36B a quarter earlier.
Buyers outnumbered sellers: 45 funds opened new ISEE positions and 23 closed out — a net gain of 22 holders — while 74 added to existing stakes and 39 trimmed.
The largest buyer was Fiera Capital (Canada), opening a new position worth an estimated $36.9M. The largest seller was Novo Holdings A/S, cutting an estimated $64.6M.
- 182 institutional investors held IVERIC bio, Inc. Common Stock (ISEE) as of Q2 2016, up from 162 in Q1 2016.
- Funds reported $1.71B of IVERIC bio, Inc. Common Stock stock for Q2 2016, up 26% quarter-over-quarter.
- 45 funds opened new IVERIC bio, Inc. Common Stock positions in Q2 2016 and 23 closed out, a net change of +22 holders.
- The largest IVERIC bio, Inc. Common Stock buyer in Q2 2016 was Fiera Capital (Canada), an estimated $36.9M added.
- The largest IVERIC bio, Inc. Common Stock seller in Q2 2016 was Novo Holdings A/S, an estimated $64.6M sold.
Based on aggregated 13F filings for Q2 2016.